Dysregulation of S100a9 has been widely observed in many inflammatory conditions (such as IBD, arthritis, dermatitis, vasculitis, systemic sclerosis, infections, and cardiovascular diseases) and human tumors (colorectal, prostate, brain, lymphoma, melanoma, and thymus cancer) (15, 44). This evidence concerns the gene S100A9 and lymphoma.